Clinical trial
Ghrelin Levels in Pancreatic Cancer Patients
NCT00225745 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00225745 |
|---|---|
| Title | Ghrelin Levels in Pancreatic Cancer Patients |
| Official title | Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Pancreatic Cancer |
| Intervention type | Procedure |
| Interventions | Blood draw |
| Enrollment | 72 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2013 |
| Completion | Sep 1, 2015 |
| First posted | Sep 26, 2005 |
| Last update posted | Oct 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: